<p>At day 42, vaccinated mice were challenged intranasally with a lethal dose (100 LD<sub>50</sub>) of recombinant H5N1 (NIBRG-14) virus and monitored daily for weight loss and mortality. The percentages of survival rate and changes of body weight and temperature were recorded. (A) Survival for H5N1-VLP groups, (B) survival for IWV groups, Mice that lost greater than 30% body weight were euthanized. (C) Body weight and temperature for H5N1-VLP groups. For th groups receiving 0.3 µg and 1.5 µg antigen dose, only data of surviving mice are shown. (D) Body weight and temperature for IWV groups.</p
<p>Groups of eight mice that received a single dose of 10<sup>6</sup> TCID<sub>50</sub> of the H5N1 ...
<p>(A–B) At six months after prime-boost immunizations with M2 VLPs, mice (n = 5) were challenged wi...
<p>Mice were immunized and boosted with various doses of Ad4 and Ad5 expressing the H3-Con consensus...
<p>At week 30 post immunization, H5N1 VLP immunized and control (PBS or 5 µg inactivated PR/8/34 H1N...
<p>Groups of mice (n = 5) were intragastrically immunized three times at day 0, 14, and 28 with PBS ...
<p>Female BALB/c mice (6−8 wk old, five mice per group) were intramuscularly immunized with 20 µg of...
<p>Each group of mice was immunized i.m. two times on days 0 and 28 with MVAtor-tri-HA or MVAtor-mon...
<p>At week 5, mice vaccinated with clade 2-dervied vaccines were challenged intranasally with a leth...
<p>Groups of mice were immunized with Ad4wt virus to establish pre-existing immunity as described pr...
<p>Mice were immunized and boosted with various doses of Ad4 and Ad5 expressing the H5-Con consensus...
<p>Mice (n = 10/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged in...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<p>Five weeks old C57B/6 were immunized with 15 µg of the indicated inactivated viruses or with 1918...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>Survival rates (A, C) and average body weight loss (B, D) of BALB/c (A, B) or C57BL/6 (C, D) mice...
<p>Groups of eight mice that received a single dose of 10<sup>6</sup> TCID<sub>50</sub> of the H5N1 ...
<p>(A–B) At six months after prime-boost immunizations with M2 VLPs, mice (n = 5) were challenged wi...
<p>Mice were immunized and boosted with various doses of Ad4 and Ad5 expressing the H3-Con consensus...
<p>At week 30 post immunization, H5N1 VLP immunized and control (PBS or 5 µg inactivated PR/8/34 H1N...
<p>Groups of mice (n = 5) were intragastrically immunized three times at day 0, 14, and 28 with PBS ...
<p>Female BALB/c mice (6−8 wk old, five mice per group) were intramuscularly immunized with 20 µg of...
<p>Each group of mice was immunized i.m. two times on days 0 and 28 with MVAtor-tri-HA or MVAtor-mon...
<p>At week 5, mice vaccinated with clade 2-dervied vaccines were challenged intranasally with a leth...
<p>Groups of mice were immunized with Ad4wt virus to establish pre-existing immunity as described pr...
<p>Mice were immunized and boosted with various doses of Ad4 and Ad5 expressing the H5-Con consensus...
<p>Mice (n = 10/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged in...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<p>Five weeks old C57B/6 were immunized with 15 µg of the indicated inactivated viruses or with 1918...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>Survival rates (A, C) and average body weight loss (B, D) of BALB/c (A, B) or C57BL/6 (C, D) mice...
<p>Groups of eight mice that received a single dose of 10<sup>6</sup> TCID<sub>50</sub> of the H5N1 ...
<p>(A–B) At six months after prime-boost immunizations with M2 VLPs, mice (n = 5) were challenged wi...
<p>Mice were immunized and boosted with various doses of Ad4 and Ad5 expressing the H3-Con consensus...